Dr. Rakesh Das

• Ph.D (Pharmaceutical Technology), Jadavpur University
• M.Pharm. in Clinical Pharmacology, Jadavpur University
• B.Pharm in Pharmacy, Tripura University (Central Govt. University)

• Drug interactions, Adverse Drug Reactions, Therapeutic Drug monitoring.
• Clinical Research & Bio-molecular evaluation study.
• Transient Energy neuro-hormonal control study.
• Detoxification and HQoL regulation efforts.

• Neuro-modulatory bio- molecular regulation and psychotic study.
• Clinical investigation and trials.

• Professor, Adamas University, Kolkata, West Bengal, India, 2023-
• Professor & Head of Pharmaceuticl Sciences, , Dayananda Sagar University, Bangalore, Karnataka, India, 2021- 2022
• Professor, Lovely University, Jalandhar, Punjab, India, 2018-19
• Assistant Professor, King Khalid University, Abha, Aseer, Kingdom of Saudi Arabia, 2012-2015
• Assistant Professor, Teerthankar Mahaveer University, Moradabad, Uttar Pradesh, India, 2015-2018
• Assistant Professor, IPS College of Pharmacy, Gwalior, MP, India, 2009- 2015.

• Number of research papers published in International refereed journals: 30
• Number of proceedings in international/National conferences: 05
• Number Books : 01
• Number of patents: 05

For Details, Visit: https://vidwan.inflibnet.ac.in/profile/337489

Selected Publication (s):

1. Rakesh Das, Dhibar S., Sarkar, S., Bachhar, J., & Roy, R. Instant energy stimulant nutraceutical cube formulation: Low endothermic promoting booster milk drink. International Journal of Health Sciences, 2022; 6 (S1): 5540-5546. https://doi.org/10.53730/ijhs.v6nS1.6107. SCOPUS-INDEX H-index-12IF- 2.96
2. Dr. Rakesh Das; Rajat Sen; Neelmani Kashyap; Tanshavi Chauhan.  Crashing of psychological state of pharmacy students on corona disaster, dwindle economy: sabotaging students career by policy makers in India. Journal of Positive school Psychology, 2022; 6(4): 5183- 5195 SCOPUS-INDEX.
3. Rakesh Das, Mohd. Almas Khan, Sourav Dhibar, Krishnendu Roy, Kousik Mahanti. Evaluation of therapeutic efficacy of gastrointestinal disorder through developed supra spinal flux neuron- impulsion detection device. Journal of East China University of Science and Technology, July, 2022; 65(3): 77-87. SCOPUS-INDEX.  DOI: 10.5281/ZENODO.6806424
4. Dr. Rakesh Das*;  Krishnendu Ray²;  Lopamudra Chakravarty²; Atreyee   Ganguly²; Shayeri Chatterjee Ganguly²Pico metallic reinforced molecular   innovated hair gel against microbial and parasitic manifestation: Clinical investigation under COVID era. NeuroQuantology, (2022).  SCOPUS-indexed.
5. Rakesh Das, Dr. (Prof.)Tapan Kr. Pal. Validation of Liquid Chromatography- Tandem Mass spectrometry for Mevalonate in human Plasma: Incompetent effects between treated Aorvastatin & its combination with Olmesartan in Cardiovascular Patients. Journal of Young Pharmacists. 2014; 6(2):50-57.[PubMed].
6. Rakesh Das, Subhasis Dan, Dr.(Prof.) Tapan Kr. Pal. Method development and validation of LCMS/MS for Aldosterone in human Plasma: Application to drug interaction study of Atorvastatin & Olmesartan Combination. Journal of Adv. Pharm. Tech. Research. 2014; 5(3), 108-114. [PubMed]
7. Rakesh Das, Dr.(Prof.) Tapan Kr. Pal. Method Development & Validation of Liquid Chromatography- Tandem mass Spectrometry for Angiotensin-II in human plasma: Application to study interaction between Atorvastatin & Olmesartan drug Combination. Indian Journal of Clinical Biochemistry, 2015, 30, pages- 334–344. (DOI:10.1007/s12291-014-0457-x) [Springer].
8. Rakesh Das, Dr.(Prof.) Tapan Kr. Pal. Assessment of Endocrinal &Biochemical entities through LCMS/MS: Inter-relative investigation of interaction based Cardiovascular formulation. Journal of Pharmacy & Bio-allied Sciences, 7(1); 2015: 49-55. [PubMed].
9. Rakesh Das, Dr. (Prof.) Tapan Kr. Pal. Endorsement of small patients population study through data mining classification: Significance to manifest Drug interaction study of Cardiovascular dosage formulation. IJPPS, 6(8); 2014: 117-122. [IF-0.924] [Innovare Academic Sciences]
10. Rakesh Das, Dr. (Prof.) Tapan Kr. Pal. Method development and validation of LCMS/MS for Atorvastatin & Olmesartan in human plasma to trace drug interaction of formulation. Current Pharmaceutical Analysis, 2015; 11(1): 43-52. [IF-0.771] [Benthan Sciences]
11. Rakesh Das, Dr. Tapan Kumar Pal. Assessment of endogenous biochemical composites emphasizing drug interaction of Cardiovascular combined dosage formulation in Marketed product. Journal of Pharmacovigilance, 2014; 2(6): 2-6. (doi: 10.4172/2329- 6887.1000150) [OMICS]

• M.PHARM: 17      Pharm. D. – 25      PhD – 2 (02 ongoing)

1. Development of single Super-Antibiotics Against entire expected Super-infections and process thereof. Patent Application Number- 202011051496; Publication Number- 49/2020; Publication Date 04/12/2020.
2. Novel Electro- thermal Transdermal Device and Process thereof. Patent Application Number- 202111033082; Publication Number- 42/2021; Publication Date 15/10/2021.
3. A novel Formulation of Panax Sokpayensis and process thereof. Patent Application Number- 202111040217; Publication Number- 21/2022; Publication Date 06/09/2021.
4. Air Condition auto regulated Jacket through transdermal drug delivery system through cold diffusion Techniques.  Patent Application Number- 202241049103; Publication Number- 40/2022; Publication Date 28/08/2022.
5. Time-specific anti-psychotic & COVID shield aromatherapy: Through designed electromagnetic pendant device. Filing process.

• Life-membership achievement awards, as 11 years active volunteer at RAMKRISHNA Mission, 21/05/2021.
• Vasu Narayan Award, Best Orator award “Limitation of clinical Approaches on modern therapy”, 2021.